J. Ting Et Al. , "Productivity losses under various second-line recurrent or metastatic cervical cancer treatment scenarios in the United States.," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16, 2022
Ting, J. Et Al. 2022. Productivity losses under various second-line recurrent or metastatic cervical cancer treatment scenarios in the United States.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16 .
Ting, J., Ayer, T., Dalgic, O. O., Erdogan, M., Yaylali, E., & Chhatwal, J., (2022). Productivity losses under various second-line recurrent or metastatic cervical cancer treatment scenarios in the United States.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16.
Ting, Jie Et Al. "Productivity losses under various second-line recurrent or metastatic cervical cancer treatment scenarios in the United States.," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16, 2022
Ting, Jie Et Al. "Productivity losses under various second-line recurrent or metastatic cervical cancer treatment scenarios in the United States.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16, 2022
Ting, J. Et Al. (2022) . "Productivity losses under various second-line recurrent or metastatic cervical cancer treatment scenarios in the United States.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16.
@article{article, author={Jie Ting Et Al. }, title={Productivity losses under various second-line recurrent or metastatic cervical cancer treatment scenarios in the United States.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2022}